Literature DB >> 15530474

Serum and plasma fragments of C-telopeptides of type I collagen (CTX) are stable during storage at low temperatures for 3 years.

P Qvist1, M Munk, N Hoyle, C Christiansen.   

Abstract

BACKGROUND: Control of pre-analytical variables is essential for successful application of biological markers, including bone resorption markers, in clinical trials and routine use. The effect of storage temperature on stability of bone resorption markers have not been subject of systematically investigation, and therefore the present study was set out to determine the stability of C-telopeptides of type I collagen (CTX) in serum and plasma samples stored frozen for 3 years.
METHODS: The serum and plasma levels of CTX were determined in samples aliquoted and stored frozen for up to 3 years.
RESULTS: No significant decrease could be detected in neither serum nor plasma samples after 3 years of storage at -20, -80 or -150 degrees C. However, at elevated temperature, i.e. 4 and 37 degrees C, improved stability of CTX was observed in EDTA plasma samples compared to serum.
CONCLUSIONS: CTX is stable in frozen serum and plasma samples for up to 3 years. EDTA plasma might be the preferred matrix due to improved stability at elevated temperatures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530474     DOI: 10.1016/j.cccn.2004.07.024

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Bone fragment or bone powder? ATR-FTIR spectroscopy-based comparison of chemical composition and DNA preservation of bones after 10 years in a freezer.

Authors:  Irena Zupanič Pajnič; Tamara Leskovar; Ivan Jerman
Journal:  Int J Legal Med       Date:  2021-05-24       Impact factor: 2.686

Review 2.  Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.

Authors:  P Szulc; K Naylor; N R Hoyle; R Eastell; E T Leary
Journal:  Osteoporos Int       Date:  2017-06-19       Impact factor: 4.507

3.  Bone resorption in dogs with calcium oxalate urolithiasis and idiopathic hypercalciuria.

Authors:  Austin C Luskin; Jody P Lulich; Sarah C Gresch; Eva Furrow
Journal:  Res Vet Sci       Date:  2019-01-04       Impact factor: 2.534

4.  Intra-articular hyaluronic acid increases cartilage breakdown biomarker in patients with knee osteoarthritis.

Authors:  Alexandra M Gonzalez-Fuentes; David M Green; Roger D Rossen; Bernard Ng
Journal:  Clin Rheumatol       Date:  2010-01-27       Impact factor: 2.980

5.  A Multicenter Study to Evaluate Harmonization of Assays for C-Terminal Telopeptides of Type I Collagen (ß-CTX): A Report from the IFCC-IOF Committee for Bone Metabolism (C-BM).

Authors:  E Cavalier; R Eastell; N R Jørgensen; K Makris; S Tournis; S Vasikaran; J A Kanis; C Cooper; H Pottel; H A Morris
Journal:  Calcif Tissue Int       Date:  2021-03-04       Impact factor: 4.333

6.  Dose-response effects of alcohol on biochemical markers of bone turnover in non-human primates: Effects of species, sex and age of onset of drinking.

Authors:  Mary Lauren Benton; Vanessa A Jimenez; Natali Newman; Steven W Gonzales; Kathleen A Grant; Russell T Turner; Urszula T Iwaniec; Erich J Baker
Journal:  Bone Rep       Date:  2021-12-11

7.  Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis.

Authors:  Thomas Lund; Niels Abildgaard; Thomas L Andersen; Jean-Marie Delaisse; Torben Plesner
Journal:  Eur J Haematol       Date:  2010-01-13       Impact factor: 2.997

Review 8.  The clinical utility of bone marker measurements in osteoporosis.

Authors:  Gillian Wheater; Mohsen Elshahaly; Stephen P Tuck; Harish K Datta; Jacob M van Laar
Journal:  J Transl Med       Date:  2013-08-29       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.